548798-25-0

Basic information

• Product Name: 2-nitro-5-phenoxybenzaldehyde
• Synonyms: 2-nitro-5-phenoxybenzaldehyde
• CAS NO: 548798-25-0
• Molecular Formula: C₁₃H₉NO₄
• Molecular Weight: 243.21486
• Mol File: 548798-25-0.mol

Chemical Properties

• Appearance: /
• Density: 1.325
• CAS DataBase Reference: 2-nitro-5-phenoxybenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-nitro-5-phenoxybenzaldehyde(548798-25-0)
• EPA Substance Registry System: 2-nitro-5-phenoxybenzaldehyde(548798-25-0)

Safety Data

• Hazardous Substances Data: 548798-25-0(Hazardous Substances Data)

Usage

InChI:InChI=1/C13H9NO4/c15-9-10-8-12(6-7-13(10)14(16)17)18-11-4-2-1-3-5-11/h1-9H

Upstream product

• 112880-83-8 5-phenoxy-2-nitrotoluene 
• 548798-20-5 2-(dimethoxymethyl)-1-nitro-4-phenoxy-benzene 
• 548798-20-5 2-(dimethoxymethyl)-1-nitro-4-phenoxy-benzene 
• 395-81-3 5-fluoro-2-nitrobenzaldehyde 
• 108-95-2 phenol 

Downstream Products

• 876761-09-0 C₂₀H₂₅N₃O₅ 
• 876762-33-3 C₃₀H₃₅N₃O₄ 
• 876762-38-8 C₂₇H₃₀N₄O₄ 
• 876762-44-6 C₂₆H₂₉N₃O₅ 
• 876762-50-4 C₃₄H₃₃N₃O₄ 
• 876763-04-1 3-(R)-tert-butoxy-2-[4-(2-nitro-5-phenoxy-benzylamino)-4-(S)-(tetrahydro-pyran-4-yl)-butyrylamino]-propionic acid methyl ester 
• 876763-12-1 3R-benzyloxy-2-{methyl-[4-(2-nitro-5-phenoxy-benzylamino)-4S-(tetrahydro-pyran-4-yl)-butyryl]-amino}-propionic acid methyl ester 
• 876763-23-4 4S,N-dicyclohexyl-4-(2-nitro-5-phenoxy-benzylamino)-N-(1H-tetrazol-5-ylmethyl)-butyramide 
• 876763-27-8 {cyclohexyl-[4S-cyclohexyl-4-(2-nitro-5-phenoxy-benzylamino)-butyryl]-amino}-acetic acid 
• 876763-40-5 C₄₅H₆₁N₃O₁₄ 
• 876762-67-3 C₃₁H₄₁N₃O₆ 
• 1397458-04-6 C₃₄H₄₄N₄O₄S 

Relevant articles and documents

Reduction of bis(5-alkyl-2-furyl)(2-nitroaryl)methane with aqueous titanium trichloride solution

In this article, we introduces a new method for the synthesis of substituted indole by reductive recyclization of bis(5-alkyl-2-furyl)(2-nitroaryl)methane. Bis(5-alkyl-2-furyl)(2-nitroaryl)methane undergo reduction to provide indole or aniline. In the pro

4-Substituted 2-amino-3,4-dihydroquinazolines with a 3-hairpin turn side chain as novel inhibitors of BACE-1

Herein, we report the identification, design, and synthesis of a series of 4-substituted 2-amino-3,4-dihydroquinazolines with hairpin turn side chains as novel inhibitors of BACE-1. The dihydroquinazoline derivatives were rationally designed by modifying the amide group and relocating the α -hydrophobic substituent on the hairpin turn side chain of lead compound 2 to the C4-position on the 3,4-dihydroquinazoline scaffold to facilitate interactions with the S1, S2 and S1′ subsites of BACE-1. Among these derivatives, two compounds exhibited potent BACE-1 inhibitory activity: 4-methyl-substituted (22a, BACE-1 CFA IC50 = 0.38 μM; BACE-1 WCA IC50 = 0.14 μM) and 4-cyclohexylmethyl-substituted (22b, BACE-1 CFA IC50 = 0.49 μM; BACE-1 WCA IC50 = 0.14 μM) 2-amino-3,4-dihydroquinazoline, each bearing a side chain of N-cyclohexyl-N-((1-methyl-1H-pyrazol-4-yl)methyl amide. The results suggest that the structural modifications maintain the hairpin turn topology similar to that of compound 2 and provide an additional interaction with the S2 subsite.

Radiolabelled MMP selective compounds

The invention is directed to radiolabelled MMP selective compounds, a processes for the preparation thereof, and uses thereof. The derivatives of the invention have formula (I) wherein Y represents O, CH2, (CH2)2, S, NH, o

2-Amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (β-site APP cleaving enzyme): Use of structure based design to convert a micromolar hit into a nanomolar lead

A new aspartic protease inhibitory chemotype bearing a 2-amino-3,4- dihydroquinazoline ring was identified by high-throughput screening for the inhibition of BACE-1. X-ray crystallography revealed that the exocyclic amino group participated in a hydrogen

2-AMINO-QUINAZOLINE DERIVATIVES USEFUL AS INHIBITORS OF B-SECRETASE (BACE)

The present invention is directed to novel 2-amino-3,4-dihydro-quinazoline derivatives, pharmaceutical compositions containing them and their use in the treatment of Alzheimer's disease (AD) and related disorders. The compounds of the invention are inhibi

NOVEL 2-AMINO-QUINAZOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE)

The present invention is directed to novel 2-amino-3, 4-dihydro-quinazoline derivatives, pharmaceutical compositions containing them and their use in the treatment of Alzheimer's disease (AD) and related disorders. The compounds of the invention are inhibitors of P-secretase, also known as n-site cleaving enzyme and BACE.